Mi Kyung Yun

Title: Mi Kyung Yun: Innovator in Metabolic and Neurologic Disorders

Introduction

Mi Kyung Yun is a prominent inventor based in Collierville, TN (US). She has made significant contributions to the field of biomedical research, particularly in the development of treatments for metabolic and neurologic disorders. With a total of three patents to her name, her work is recognized for its potential impact on healthcare.

Latest Patents

One of her latest patents focuses on small molecule modulators of pantothenate kinases. This invention relates to chemical compounds that modulate pantothenate kinase (PanK) activity for the treatment of metabolic disorders, such as type II diabetes mellitus, and neurologic disorders, including pantothenate kinase-associated neurodegeneration. The patent outlines pharmaceutical compositions containing these compounds and their applications in treatment. Another significant patent involves methods of treating disorders associated with coenzyme A reduction, elevation, sequestration, toxicity, or redistribution (CASTOR) disease. This includes defects in fatty acid oxidation enzymes and other related conditions, utilizing small molecule modulators of CoA levels.

Career Highlights

Mi Kyung Yun has worked with esteemed organizations such as St. Jude Children's Research Hospital and Coa Therapeutics, Inc. Her experience in these institutions has allowed her to collaborate on groundbreaking research and innovations in her field.

Collaborations

Some of her notable coworkers include Richard Edward Lee and Charles O Rock. Their collaborative efforts have contributed to the advancement of research in metabolic and neurologic disorders.

Conclusion

Mi Kyung Yun is a dedicated inventor whose work in developing treatments for complex health issues showcases her commitment to improving patient outcomes. Her innovative patents and collaborations highlight her significant role in the scientific community.